The proinflammatory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions.
about
Neurokinin-1 receptor antagonists as antitumor drugs in gastrointestinal cancer: A new approachCytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction.Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors.The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.Application of GFP imaging in cancer.Overview of Glutamatergic Dysregulation in Central Pathologies.Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression.In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.Brain metastasis in breast cancer: a comprehensive literature review.Transendothelial Transport and Its Role in Therapeutics.The role of claudins in cancer metastasis.The cancer chemotherapeutic agent paclitaxel (Taxol) reduces hippocampal neurogenesis via down-regulation of vesicular zinc.Novel cytogenic and neurovascular niches due to blood-brain barrier compromise in the chronic pain brain.The small vesicular culprits: the investigation of extracellular vesicles as new targets for cancer treatment.Blood-brain barrier dysfunction and recovery after ischemic stroke.Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1.Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases.[Tumor microenvironment--the critical element of tumor metastasis].
P2860
Q26739681-7E1C29D3-3422-46E5-80F0-BD22292285CBQ30390049-9953BB96-77D4-48E4-B44E-6C7A9CE2A4AFQ33599638-44B9EB58-178F-4431-8738-40930FCCA942Q34475975-19D0FEA4-C7A7-4CDD-9889-38B8BE2A0174Q35251651-AD406290-DB9C-442D-A15C-96F2E7B4DE13Q36409596-07368AED-781A-4722-8FF2-E1BE22FE0B3DQ37605157-3FBFA354-E4F8-4A85-96AA-A54A593569A7Q38730069-9EB4126C-1238-4A6D-833D-B997F2A3C8AEQ38748013-98265E26-1135-4688-A87D-54F0CE71D780Q38880426-1D6230B9-80A5-4257-A4DD-B3AA88AF015BQ38927656-AC955494-BB11-4B4F-AD45-2AD1158D420EQ41718205-EBFA3A83-36B8-487B-9420-5E5B21AC3706Q43227382-1FFAF786-1456-4958-A46E-58920E826140Q47128288-B588E36C-BE70-4E1D-967A-87F51D10C8ABQ47910464-882DF0F9-3813-4EA3-8C85-317B7A112678Q47911670-ADDB493F-8B12-4DD4-8657-90D97BB85B99Q48108646-FA34F7AE-2F4A-49ED-B9F7-C67571E8440FQ53639987-42AA2510-DB4B-4A16-84B1-61486B580D9D
P2860
The proinflammatory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The proinflammatory peptide su ...... othelial cell tight junctions.
@en
The proinflammatory peptide su ...... othelial cell tight junctions.
@nl
type
label
The proinflammatory peptide su ...... othelial cell tight junctions.
@en
The proinflammatory peptide su ...... othelial cell tight junctions.
@nl
prefLabel
The proinflammatory peptide su ...... othelial cell tight junctions.
@en
The proinflammatory peptide su ...... othelial cell tight junctions.
@nl
P2093
P921
P356
P1476
The proinflammatory peptide su ...... othelial cell tight junctions.
@en
P2093
Hava Karsenty Avraham
Pedro L Rodriguez
Shalom Avraham
Shuxian Jiang
P304
P356
10.1002/IJC.28433
P577
2013-09-03T00:00:00Z